Nitrosamine Impurities Application Guide - Confidently Detect and Quantify Mutagenic Impurities in APIs and Drug Products
Příručky, Prezentace | 2020 | Agilent TechnologiesInstrumentace
GC/MSD, GC/MS/MS, HeadSpace, GC/SQ, GC/QQQ, LC/TOF, LC/HRMS, LC/MS, LC/MS/MS, LC/QQQ
ZaměřeníFarmaceutická analýza
VýrobceAgilent Technologies
Klíčová slovaback, ndma, neipa, fda, ndipa, ndea, ndba, metformin, nitrosamine, introduction, api, valsartan, best, quant, dichloromethan, candesartan, telmisartan, ranitidine, sartan, substance, losartan, filter, sample, drug, curves, sonicate, preparation, optimized, supernatant, method, time, counts, vial, impurities, calibrations, temperature, scalable, per, labs, name, masshunter, centrifugation, recovery, paper, irbesartan, olmesartan, drugs, rugged, easy, calibration
Podobná PDF
Nitrosamines Analysis in Pharmaceuticals - Consumables workflow ordering guide
2021|Agilent Technologies|Příručky
Nitrosamines Analysis in Pharmaceuticals Using Single Quadrupole GC/MS or Triple Quadrupole GC/MS Consumables workflow ordering guide R1 N N R2 R O 2 R 1 R N N 2 R 1 R O R 2 1 N N N N…
Klíčová slova
nitrosamine, nitrosaminenitrosamines, nitrosaminesndma, ndmandea, ndeamylist, mylistfavorite, favoriteneipa, neipandipa, ndipadrug, drugppm, ppmitems, itemsinlet, inletclick, clickreplacement, replacementsupplies
Quantification of Nitrosamine Impurities in Metformin Using Agilent GC/MS/MS Instrumentation
2020|Agilent Technologies|Aplikace
Application Note Pharma and Biopharma Quantification of Nitrosamine Impurities in Metformin Using Agilent GC/MS/MS Instrumentation Authors Soma Dasgupta, Vivek Dhyani, Samir Vyas, and Melissa Churley, Agilent Technologies, Inc. Abstract Since June 2018, several drugs were recalled due to the presence…
Klíčová slova
ndma, ndmandea, ndeacounts, countsacquisition, acquisitiondrug, drugname, namendba, ndbanitrosamine, nitrosaminemin, minneipa, neipandipa, ndipaweighed, weighedϭϭϯ, ϭϭϯїϱϲ͘ϭ͕, їϱϲ͘ϭ͕time
Analysis of Five Nitrosamine Impurities in Drug Products and Drug Substances Using Agilent GC/MS/MS Instrumentation
2020|Agilent Technologies|Aplikace
Application Note Pharma & Biopharma Analysis of Five Nitrosamine Impurities in Drug Products and Drug Substances Using Agilent GC/MS/MS Instrumentation Authors Soma Dasgupta, Lalith Hansoge, Vivek Dhyani, Samir Vyas, and Melissa Churley Agilent Technologies, Inc. Abstract This application note highlights…
Klíčová slova
relative, relativeresponses, responsesndba, ndbaneipa, neipandipa, ndipandma, ndmaotr, otrndea, ndeastd, stdfda, fdacounts, countsconcentration, concentrationacquisition, acquisitiondrug, drugimpurities
Analysis of Pharmaceuticals’ Impurity - Regulations and Analysis for Carcinogenic Substances -
2020|Shimadzu|Příručky
Application Note No. 62 Analysis of Pharmaceuticals’ Impurity - Regulations and Analysis for Carcinogenic Substances Dheeraj Handique *a), Nitish Suryawanshi *a), Crystal Yeong *b), Cynthia Lahey *b), Shailendra Rane *a), Deepti Bhandarkar *a), Anant Lohar *a), Gao Jie san *c),…
Klíčová slova
ndma, ndmandea, ndeacarcinogenic, carcinogenicsubstances, substancesmutagenic, mutagenicmms, mmsems, emsimpurity, impuritymode, modeims, imsdrug, drugmutagenicity, mutagenicityolmesartan, olmesartanndba, ndbapharmaceuticals